Literature DB >> 11741538

The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction.

Y Wan1, X Liu, M W Kirschner.   

Abstract

Degradation of SnoN is thought to play an important role in the transactivation of TGF-beta responsive genes. We demonstrate that the anaphase-promoting complex (APC) is a ubiquitin ligase required for the destruction of SnoN and that the APC pathway is regulated by TGF-beta. The destruction box of SnoN is required for its degradation in response to TGF-beta signaling. Furthermore, the APC activator CDH1 and Smad3 synergistically regulate SnoN degradation. Under these circumstances, CDH1 forms a quaternary complex with SnoN, Smad3, and APC. These results suggest that APC(CDH1) and SnoN play central roles in regulating growth through the TGF-beta signaling system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741538     DOI: 10.1016/s1097-2765(01)00382-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  80 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Authors:  Hideaki Naoe; Kimi Araki; Osamu Nagano; Yusuke Kobayashi; Jo Ishizawa; Tatsuyuki Chiyoda; Takatsune Shimizu; Ken-ichi Yamamura; Yutaka Sasaki; Hideyuki Saya; Shinji Kuninaka
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

3.  Global control of histone modification by the anaphase-promoting complex.

Authors:  Vijay Ramaswamy; Jessica S Williams; Karen M Robinson; Richelle L Sopko; Michael C Schultz
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

4.  Loss of the anaphase-promoting complex in quiescent cells causes unscheduled hepatocyte proliferation.

Authors:  Karin G Wirth; Romeo Ricci; Juan F Giménez-Abián; Shahryar Taghybeeglu; Nobuaki R Kudo; Wolfram Jochum; Mireille Vasseur-Cognet; Kim Nasmyth
Journal:  Genes Dev       Date:  2004-01-01       Impact factor: 11.361

5.  Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression.

Authors:  Davide Gabellini; Ivan N Colaluca; Hartmut C Vodermaier; Giuseppe Biamonti; Mauro Giacca; Arturo Falaschi; Silvano Riva; Fiorenzo A Peverali
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

6.  Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase.

Authors:  Agata Zieba; Katerina Pardali; Ola Söderberg; Lena Lindbom; Erik Nyström; Aristidis Moustakas; Carl-Henrik Heldin; Ulf Landegren
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

7.  Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress.

Authors:  Liyong Zhang; Chi-Hoon Park; Jing Wu; Hyun Kim; Weijun Liu; Takeo Fujita; Manimalha Balasubramani; Emanuel M Schreiber; Xiao-Fan Wang; Yong Wan
Journal:  EMBO J       Date:  2010-04-27       Impact factor: 11.598

Review 8.  APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity.

Authors:  Xinxian Qiao; Liyong Zhang; Armin M Gamper; Takeo Fujita; Yong Wan
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

9.  The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.

Authors:  Han Lu; Bin Liu; Fu-Jun Zhang; Jin Zhang; Rong Dong; Lei Chen; Dong-Mei Qu; Yan Lu; Bu-Wei Yu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.